论文信息 - Assessment of DDR 2 , BRAF , EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients - 字舞流文

Assessment of DDR 2 , BRAF , EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients

Koujirou Yamamoto | I. Takeyoshi | K. Shimizu | Yasuaki Enokida | T. Nagashima | J. Atsumi | Y. Ohtaki | T. Araki | H. Yashima | Tomonori Nakamura | T. Aomori